Clinical Trial Update: Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating Shensong Yangxin Capsule for heart failure complicated by premature ventricular contractions (PVCs).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Premature Ventricular Contractions

Drugs mentioned

• Shensong Yangxin Capsule

Snippet

Sponsor: Cong-xin Huang | Conditions: Heart Failure, Ventricular Premature Complex | Phase 4 | Status: UNKNOWN